Dr. James Suliburk is a board-certified surgeon specializing in the treatment of tumors of the thyroid, parathyroid, and adrenal gland in Houston and the surrounding area (Bryan-College Station, Austin, San Antonio, Corpus Christi and Beaumont). As a fellowship-trained endocrine surgeon, he specializes in the care of patients with thyroid nodules, goiter, Graves’ disease, thyroid cancer, hyperparathyroidism, adrenal masses, pheochromocytoma, Cushing’s, and Conn’s diseases. His advanced surgical expertise includes minimally invasive parathyroidectomy and thyroidectomy, traditional open thyroidectomy, central, selective and modified radical neck dissection, single incision laparoscopic adrenalectomy, and traditional laparoscopic adrenalectomy.
He conducts research on the clinical outcomes in endocrine surgery in underserved and minority populations, outcomes in acute care and trauma surgery, and in the application of mobile technology to improve peri-operative surgical care and communication with patients to detect of impending complications. His research program at Ben Taub Hospital and Baylor St. Luke’s CHI Medical Center offers opportunities in translational science, clinical outcomes, and mobile technology development/innovation. The research comes from the establishment of comprehensive and multidisciplinary treatment pathways within the endocrine surgical programs at Ben Taub Hospital and Baylor Clinic. In addition Dr. Suliburk works with other colleagues within Baylor College of Medicine to actively seek and develop state of the art treatments for hemorrhagic shock severely injured trauma patients. Translational research opportunities include development of novel molecular markers and therapeutic targets in endocrine surgical disease (thyroid cancer, hyperthyroidism, hyperparathyroidism, and adrenal tumors), as well as metabolic markers of the endocrine response in severely injured major trauma patients.
American Board of Surgery